Patent · US Expired

Ku deficient cells and non-human transgenic animals

US5955644A · kind A · utility

1Cited by
4References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 8, 1996
Grant dateSep 21, 1999
Priority date
Expiry dateAug 8, 2016

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2517/02
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Ku deficient cells and transgenic animals are described that comprise at least one allele of the XRCC5 gene that has been mutated by targeted disruption. Fibroblasts derived from XRCC5 mutant embryos and mice were found to prematurely age. These cells displayed decreased growth, slow entry into S phase, altered colony size distribution that favored small colonies, short life span and morphology characteristic of terminal differentiation. Mutant cells were also hypersensitive to .gamma.-radiation. The tissue culture data was at least partly reproduced in vivo because mutant mice grew slower than control littermates. The XRCC5 mutation, designated xrcc5.sup.M1, was a deletion of nucleotides 701-964 that shifted the reading frame. xrcc5.sup.M1 is expected to be null because the deleted allele produced no detectable transcript and because lymphocyte development and V(D)J recombination was severely disrupted.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.